Modulation of Inflammatory Mediators by Polymeric Nanoparticles Loaded with Anti-Inflammatory Drugs
The first-line treatment of osteoarthritis is based on anti-inflammatory drugs, the most currently used being nonsteroidal anti-inflammatory drugs, selective cyclooxygenase 2 (COX-2) inhibitors and corticoids. Most of them present cytotoxicity and low bioavailability in physiological conditions, mak...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/2/290 |
id |
doaj-a35fe16e9555481fb78498efd797c946 |
---|---|
record_format |
Article |
spelling |
doaj-a35fe16e9555481fb78498efd797c9462021-02-24T00:05:08ZengMDPI AGPharmaceutics1999-49232021-02-011329029010.3390/pharmaceutics13020290Modulation of Inflammatory Mediators by Polymeric Nanoparticles Loaded with Anti-Inflammatory DrugsGloria María Pontes-Quero0Lorena Benito-Garzón1Juan Pérez Cano2María Rosa Aguilar3Blanca Vázquez-Lasa4Group of Biomaterials, Department of Polymeric Nanomaterials and Biomaterials, Institute of Polymer Science and Technology, ICTP-CSIC, Juan de la Cierva 3, 28006 Madrid, SpainFaculty of Medicine, University of Salamanca, 37007 Salamanca, SpainAlodia Farmacéutica SL, Santiago Grisolía 2 D130/L145, 28760 Madrid, SpainGroup of Biomaterials, Department of Polymeric Nanomaterials and Biomaterials, Institute of Polymer Science and Technology, ICTP-CSIC, Juan de la Cierva 3, 28006 Madrid, SpainGroup of Biomaterials, Department of Polymeric Nanomaterials and Biomaterials, Institute of Polymer Science and Technology, ICTP-CSIC, Juan de la Cierva 3, 28006 Madrid, SpainThe first-line treatment of osteoarthritis is based on anti-inflammatory drugs, the most currently used being nonsteroidal anti-inflammatory drugs, selective cyclooxygenase 2 (COX-2) inhibitors and corticoids. Most of them present cytotoxicity and low bioavailability in physiological conditions, making necessary the administration of high drug concentrations causing several side effects. The goal of this work was to encapsulate three hydrophobic anti-inflammatory drugs of different natures (celecoxib, tenoxicam and dexamethasone) into core-shell terpolymer nanoparticles with potential applications in osteoarthritis. Nanoparticles presented hydrodynamic diameters between 110 and 130 nm and almost neutral surface charges (between −1 and −5 mV). Encapsulation efficiencies were highly dependent on the loaded drug and its water solubility, having higher values for celecoxib (39–72%) followed by tenoxicam (20–24%) and dexamethasone (14–26%). Nanoencapsulation reduced celecoxib and dexamethasone cytotoxicity in human articular chondrocytes and murine RAW264.7 macrophages. Moreover, the three loaded systems did not show cytotoxic effects in a wide range of concentrations. Celecoxib and dexamethasone-loaded nanoparticles reduced the release of different inflammatory mediators (NO, TNF-α, IL-1β, IL-6, PGE<sub>2</sub> and IL-10) by lipopolysaccharide (LPS)-stimulated RAW264.7. Tenoxicam-loaded nanoparticles reduced NO and PGE<sub>2</sub> production, although an overexpression of IL-1β, IL-6 and IL-10 was observed. Finally, all nanoparticles proved to be biocompatible in a subcutaneous injection model in rats. These findings suggest that these loaded nanoparticles could be suitable candidates for the treatment of inflammatory processes associated with osteoarthritis due to their demonstrated in vitro activity as regulators of inflammatory mediator production<b>.</b>https://www.mdpi.com/1999-4923/13/2/290celecoxib, tenoxicam, dexamethasone, osteoarthritis, inflammatory mediators, nanoparticles |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Gloria María Pontes-Quero Lorena Benito-Garzón Juan Pérez Cano María Rosa Aguilar Blanca Vázquez-Lasa |
spellingShingle |
Gloria María Pontes-Quero Lorena Benito-Garzón Juan Pérez Cano María Rosa Aguilar Blanca Vázquez-Lasa Modulation of Inflammatory Mediators by Polymeric Nanoparticles Loaded with Anti-Inflammatory Drugs Pharmaceutics celecoxib, tenoxicam, dexamethasone, osteoarthritis, inflammatory mediators, nanoparticles |
author_facet |
Gloria María Pontes-Quero Lorena Benito-Garzón Juan Pérez Cano María Rosa Aguilar Blanca Vázquez-Lasa |
author_sort |
Gloria María Pontes-Quero |
title |
Modulation of Inflammatory Mediators by Polymeric Nanoparticles Loaded with Anti-Inflammatory Drugs |
title_short |
Modulation of Inflammatory Mediators by Polymeric Nanoparticles Loaded with Anti-Inflammatory Drugs |
title_full |
Modulation of Inflammatory Mediators by Polymeric Nanoparticles Loaded with Anti-Inflammatory Drugs |
title_fullStr |
Modulation of Inflammatory Mediators by Polymeric Nanoparticles Loaded with Anti-Inflammatory Drugs |
title_full_unstemmed |
Modulation of Inflammatory Mediators by Polymeric Nanoparticles Loaded with Anti-Inflammatory Drugs |
title_sort |
modulation of inflammatory mediators by polymeric nanoparticles loaded with anti-inflammatory drugs |
publisher |
MDPI AG |
series |
Pharmaceutics |
issn |
1999-4923 |
publishDate |
2021-02-01 |
description |
The first-line treatment of osteoarthritis is based on anti-inflammatory drugs, the most currently used being nonsteroidal anti-inflammatory drugs, selective cyclooxygenase 2 (COX-2) inhibitors and corticoids. Most of them present cytotoxicity and low bioavailability in physiological conditions, making necessary the administration of high drug concentrations causing several side effects. The goal of this work was to encapsulate three hydrophobic anti-inflammatory drugs of different natures (celecoxib, tenoxicam and dexamethasone) into core-shell terpolymer nanoparticles with potential applications in osteoarthritis. Nanoparticles presented hydrodynamic diameters between 110 and 130 nm and almost neutral surface charges (between −1 and −5 mV). Encapsulation efficiencies were highly dependent on the loaded drug and its water solubility, having higher values for celecoxib (39–72%) followed by tenoxicam (20–24%) and dexamethasone (14–26%). Nanoencapsulation reduced celecoxib and dexamethasone cytotoxicity in human articular chondrocytes and murine RAW264.7 macrophages. Moreover, the three loaded systems did not show cytotoxic effects in a wide range of concentrations. Celecoxib and dexamethasone-loaded nanoparticles reduced the release of different inflammatory mediators (NO, TNF-α, IL-1β, IL-6, PGE<sub>2</sub> and IL-10) by lipopolysaccharide (LPS)-stimulated RAW264.7. Tenoxicam-loaded nanoparticles reduced NO and PGE<sub>2</sub> production, although an overexpression of IL-1β, IL-6 and IL-10 was observed. Finally, all nanoparticles proved to be biocompatible in a subcutaneous injection model in rats. These findings suggest that these loaded nanoparticles could be suitable candidates for the treatment of inflammatory processes associated with osteoarthritis due to their demonstrated in vitro activity as regulators of inflammatory mediator production<b>.</b> |
topic |
celecoxib, tenoxicam, dexamethasone, osteoarthritis, inflammatory mediators, nanoparticles |
url |
https://www.mdpi.com/1999-4923/13/2/290 |
work_keys_str_mv |
AT gloriamariapontesquero modulationofinflammatorymediatorsbypolymericnanoparticlesloadedwithantiinflammatorydrugs AT lorenabenitogarzon modulationofinflammatorymediatorsbypolymericnanoparticlesloadedwithantiinflammatorydrugs AT juanperezcano modulationofinflammatorymediatorsbypolymericnanoparticlesloadedwithantiinflammatorydrugs AT mariarosaaguilar modulationofinflammatorymediatorsbypolymericnanoparticlesloadedwithantiinflammatorydrugs AT blancavazquezlasa modulationofinflammatorymediatorsbypolymericnanoparticlesloadedwithantiinflammatorydrugs |
_version_ |
1724253492151844864 |